Auto Immune
The Autoimmune Unit was officially established in April 2018, with the aim to provide cutting-edge products of top global pharmaceutical companies to improve the health and quality of life of patients suffering from autoimmune disease.
Patients with autoimmune diseases are subject to multiple and complex chronic treatments. BSC is committed to provide top quality, evidence based medications approved by FDA and/or EMEA, to address the unmet needs of patients, Physicians and health care providers.
The Autoimmune Unit covers the following areas:
- Multiple Sclerosis
- Psoriasis/ Psoriatic Arthritis
- Rheumatoid Arthritis
- Taltz®
- Olumiant®
- Aubagio®
- Lemtrada®
